Ejaculatory dysfunction in the treatment of lower urinary tract symptoms - Wikidata - wikimedia - TriplyDB

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

http://www.wikidata.org/entity/Q28073775

about

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

http://www.wikidata.org/entity/Q28073775

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@ast

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@en

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@nl

type

label

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@ast

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@en

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@nl

prefLabel

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@ast

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@en

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@nl

P1433

Q28073775-435132FB-BC45-4C5D-BBD0-F247612FC150

P1476

Q28073775-08B46CFA-7723-4E77-9164-C47F1CB1CDF8

P2093

Q28073775-06D74EDB-FFFE-4D60-B7C2-9270ACE1FC82

Q28073775-3FC8CF5E-41A6-4C24-84DF-8101234911B3

Q28073775-E1A89521-5868-4C54-B0F7-4F8A5E467DCF

P2860

Q28073775-01C56F0B-7BC4-46CA-8BA7-0A4C3525E61C

Q28073775-11BD4978-BC45-419B-B145-ECDDF02B7DD5

Q28073775-190094B9-E000-4F19-A8EB-18CE92524472

Q28073775-194EFA0D-510B-4604-B13C-7BD91C16E0BC

Q28073775-1989F13B-F1D2-488E-AAEA-3D6CC7CE9F22

Q28073775-2095D9C9-F938-4D41-9B4A-3B811787B61C

Q28073775-20DDD35C-6EBD-4460-8F28-22564E05F74D

Q28073775-221DEFC8-736E-4FD0-9F8D-D5FDFAD6180F

Q28073775-24052227-C100-4811-A093-F7EE8C72144A

Q28073775-26C2FB15-B065-418E-8B09-A96425B09962

P304

Q28073775-3C8A2F7A-F5A9-45AE-B642-8C99FF4A5711

P31

Q28073775-A67AD9E8-FC33-4363-BE0D-3FBB78604329

P3181

Q28073775-DADA336C-596F-4E21-BED4-616C22F000F2

P356

Q28073775-C5491B86-2AA2-4E60-9369-5A932D0434FA

P407

Q28073775-FA55C97B-6806-4D71-976B-047D5EAAC1F3

P433

Q28073775-DE8BB009-E11F-4C09-816A-1C1193E4B050

P478

Q28073775-2D8D2CE4-2215-4D56-AEAF-20DA06D058AF

P577

Q28073775-634D148A-5152-4483-AD50-F0C661F3A55A

P698

Q28073775-AED63BEE-D1BA-4A80-B5B8-0E2270A313CE

P932

Q28073775-ECE8D4D1-A5E5-4E41-970B-DF42A3E86365

P3181

P356

P1433

Translational andrology and urology

P1476

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms

@en

P2093

Kenneth Jackson DeLay

http://www.w3.org/2001/XMLSchema#string

Kevin T. McVary

http://www.w3.org/2001/XMLSchema#string

Max Nutt

http://www.w3.org/2001/XMLSchema#string

P2860

Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration

The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study

A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.

Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients.

A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years.

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.

Persistent sexual side effects of finasteride for male pattern hair loss.

A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with α-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia.

Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers.

P304

450-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4360881

http://www.w3.org/2001/XMLSchema#string

P356

10.21037/TAU.2016.06.06

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27652217

http://www.w3.org/2001/XMLSchema#string

P932

5002000

http://www.w3.org/2001/XMLSchema#string